Zenta Tsuchihashi

Zenta Tsuchihashi, PhD, has extensive experience in the field of oncology and translational science, currently serving as Senior Director of Translational Science at Daiichi Sankyo, Inc., focusing on DS-8201/ENHERTU and ADC Safety. Previous positions include Senior Medical Science Liaison in oncology at AstraZeneca, Director of Medical Affairs - Oncology at Daiichi Sankyo, Biomarker Program Leader for Afinitor at Novartis, and Group Leader for Immuno-Oncology Biomarkers at Bristol-Myers Squibb. Zenta Tsuchihashi holds a post-doctoral fellowship in Biochemistry from Stanford University and a Bachelor's degree in Pharmaceutical Sciences from The University of Tokyo.